Grant: Catalyst Grant: eHealth Innovations - Aging
McGill University
$76,336.00
Adjuvant Endocrine Therapy in Breast Cancer: A Novel E-health Approach in Optimizing Treatment Adherence in Seniors
FY 2013-14
Summary
Anti-estrogen therapy is an effective breast cancer treatment, decreasing the risk of recurrence and death by 40%. To benefit from it, patients must take a daily pill for five years. Studies show that a third of patients have difficulty completing five years of therapy, because of side effects, other health issues or lack of support. This means that many women face the unnecessary risk of avoidable breast cancer recurrence.
Doctors and nurses are often not aware that their patients are having challenges completing five years of treatment. After all, patients self-administer the anti-estrogen pills, with minimal contact with the care team. This is particularly true for seniors with breast cancer. Over 40% of new breast cancers occur in women >65 years old. These patients are at higher risk of discontinuing anti-estrogen therapy, even if they benefit the most from it. Older women can encounter other health issues during the five years of treatment that will negatively affect the completion of their anti-cancer therapy (ER visits, hospitalizations, new drugs, etc). They are also more prone to abandon treatment before completion. Seniors with breast cancer thus represent a high risk population.
We propose an electronic breast cancer care optimization tool targeting specifically the needs of older women with breast cancer. Every transaction within the health care system (doctor, pharmacist, hospital) generates an administrative claim. These are stored in data repositories and are a rich source of health service use information. The e-health tool we propose will access these records and continuously process data, providing the most accurate snap shot of treatments at any given time. By providing this type of real-time information specific to each patient in the form of alerts, our e-health tool will allow cancer care teams to optimize breast cancer survival, by targeting efforts on patients having recently discontinued treatment or at risk for discontinuing therapy.
Department
Program
Catalyst Grant: eHealth Innovations - Aging
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
307661
Name
Meguerditchian Ari N
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Health systems / services
Prcname2
e-Health Innovation Partnership Program (eHIPP)
Projecttitle
Adjuvant Endocrine Therapy in Breast Cancer: A Novel E-health Approach in Optimizing Treatment Adherence in Seniors
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$76,336
Cihrequipment2
$0
Programname2
Catalyst Grant: eHealth Innovations - Aging
Keyworddelim
Adherence; Anti-Estrogen Therapy; Breast Cancer; Cancer Care Trajectories; E-Health; Geriatric Oncology; Guideline Compliance
Abstract
Anti-estrogen therapy is an effective breast cancer treatment, decreasing the risk of recurrence and death by 40%. To benefit from it, patients must take a daily pill for five years. Studies show that a third of patients have difficulty completing five years of therapy, because of side effects, other health issues or lack of support. This means that many women face the unnecessary risk of avoidable breast cancer recurrence.
Doctors and nurses are often not aware that their patients are having challenges completing five years of treatment. After all, patients self-administer the anti-estrogen pills, with minimal contact with the care team. This is particularly true for seniors with breast cancer. Over 40% of new breast cancers occur in women >65 years old. These patients are at higher risk of discontinuing anti-estrogen therapy, even if they benefit the most from it. Older women can encounter other health issues during the five years of treatment that will negatively affect the completion of their anti-cancer therapy (ER visits, hospitalizations, new drugs, etc). They are also more prone to abandon treatment before completion. Seniors with breast cancer thus represent a high risk population.
We propose an electronic breast cancer care optimization tool targeting specifically the needs of older women with breast cancer. Every transaction within the health care system (doctor, pharmacist, hospital) generates an administrative claim. These are stored in data repositories and are a rich source of health service use information. The e-health tool we propose will access these records and continuously process data, providing the most accurate snap shot of treatments at any given time. By providing this type of real-time information specific to each patient in the form of alerts, our e-health tool will allow cancer care teams to optimize breast cancer survival, by targeting efforts on patients having recently discontinued treatment or at risk for discontinuing therapy.
Competitiondate
201310
Approvedterm2
1 yr 0 mth
Pinamesdelim
Meguerditchian, Ari N
Approvedterm
1 an 0 mois
Cihrcontribution2
Institute of Aging~ $76,336~ $0~